cj, thanks, as always. do you really think the FDA is going to approve a drug for a given indication when the trial for that indication was stopped "for futility"? I am not saying it is impossible, but I am saying that I would not buy any more stock on that premise.
You don't have to hedge. It is impossible. The FDA would NEVER approve ANY drug for an indication where the pivotal phase III trial was stopped for futility at the first look in. How in the world can this still be a topic of discussion?
Market Data 
Markets 
AI
